ESMC — Escalon Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $1.30m
- -$1.26m
- $12.05m
Annual cashflow statement for Escalon Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.018 | 0.457 | -0.125 | 0.106 | 4.01 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.227 | 0.29 | 0.304 | 0.211 | -2.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.89 | -0.466 | -0.827 | 0.026 | -0.599 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1.05 | 0.325 | -0.603 | 0.381 | -0.403 |
| Capital Expenditures | 0 | -0.014 | -0.04 | -0.004 | -0.004 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | 2.8 |
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.014 | -0.04 | -0.004 | 2.8 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.007 | -0.015 | -0.037 | -0.04 | -0.13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.06 | 0.296 | -0.681 | 0.337 | 2.26 |